3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
6
Oropharyngeal Neoplasms
5
Lung Neoplasms
5
Carcinoma, Non-Small-Cell Lung
4
Urinary Bladder Neoplasms
3
Nasopharyngeal Carcinoma
3
Mouth Neoplasms
3
Mesothelioma, Malignant
3
Laryngeal Neoplasms
3
Carcinoma
3
Uterine Cervical Neoplasms
2
Pancreatic Neoplasms
2
Lymphoid Interstitial Pneumonia
2
Hypopharyngeal Neoplasms
2
Ganglioneuroblastoma
2
Cholangiocarcinoma
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Tongue Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Sinonasal Squamous Cell Carcinoma
1
Salivary Gland Neoplasms
1
Resectable Intrahepatic Cholangiocarcinoma
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Osteosarcoma
1
Neuroblastoma
1
Mesothelioma
1
Medulloblastoma
1
Locally Advanced Cervical Adenocarcinoma
1
Interventions
atezolizumab
1
Sorafenib
1
Cyclophosphamide
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fibrolamellar hepatocellular carcinoma
×
1,2-diaminocyclohexaneplatinum II citrate
×
30 days
×
Clear all
No trials found.